Document Detail

CA 125: a potential tumor marker for gallbladder cancer.
MedLine Citation:
PMID:  16724349     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: CA 125 is a glycoprotein and a commonly used tumor marker in ovarian carcinoma. Its use in gallbladder carcinoma (GBC) has not yet been reported. We have henceforth examined for the first time the diagnostic utility of CA 125 in patients with gallbladder diseases. PATIENTS AND METHODS: Serum CA 125 was measured in 64 patients with GBC, 47 Gallstone disease (GSD) and 23 healthy volunteers by ELISA. CA 125 level was compared between different cohorts by non-parametric test (Kruskal Wallis and Mann-Whitney test). Receiver operating characteristic curve (ROC) was constructed to see the diagnostic utility of CA 125. Its level was also correlated with age, sex and clinico-pathological parameters of the patients included in the study. RESULTS: Mean value of CA 125 in patients with GBC, GSD and healthy volunteers was 77.44 +/- 141.31 U/ml, 7.85 +/- 5.40 U/ml, and 8.08 +/- 3.26 U/ml respectively and showed a statistically significant difference (P < 0.001). CA 125 at cut off value of 11 U/ml yielded 64% sensitivity and 90% specificity in differentiating benign from malignant gallbladder disease. CA 125 level increased with stage and grade of the GBC though this was not statistically significant. A higher level of CA 125 was found in presence of gallbladder mass, weight loss, ascites and loss of appetite compared to patients with GSD. No association of CA 125 was apparent with either age or sex of the patients. CONCLUSION: CA 125 has a diagnostic potential for GBC and can differentiate GBC from GSD in light of other clinical details.
Amita Chaube; Mallika Tewari; Usha Singh; H S Shukla
Related Documents :
2020619 - Immunoscintigraphy of prostatic cancer: preliminary results with 111in-labeled monoclon...
8256569 - Cavernous angiomatosis of the central nervous system: usefulness of screening the family.
12975539 - Elevated serum ca 125 levels in mitral stenotic patients with heart failure.
19562349 - The difference in oxidative stress of the blood between using 5% glucose water and dist...
12230619 - (125)iodine prostate brachytherapy: outcome from the first 100 consecutive patients and...
8994739 - Creatine kinase isoforms as circulating markers of deterioration in idiopathic dilated ...
23406829 - Brain natriuretic peptide as a predictor of cardioembolism in acute ischemic stroke pat...
7848789 - Doxazosin in hypertension: results of a general practice study in 4809 patients.
1360199 - Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of surgical oncology     Volume:  93     ISSN:  0022-4790     ISO Abbreviation:  J Surg Oncol     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-31     Completed Date:  2006-06-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0222643     Medline TA:  J Surg Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  665-9     Citation Subset:  IM    
Copyright Information:
Copyright 2006 Wiley-Liss, Inc.
Department of Pathology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Ascites / diagnosis
CA-125 Antigen / blood*
Enzyme-Linked Immunosorbent Assay
Gallbladder Neoplasms / diagnosis*,  pathology
Gallstones / diagnosis
Lymph Nodes / pathology
Neoplasm Staging
ROC Curve
Sensitivity and Specificity
Tumor Markers, Biological / blood*
Reg. No./Substance:
0/CA-125 Antigen; 0/Tumor Markers, Biological

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  K-ras, p53 mutations, and microsatellite instability (MSI) in gallbladder cancer.
Next Document:  Laparoscopic cholecystectomy and gallbladder cancer.